Signaling crosstalk between PPAR γ and BMP2 in mesenchymal stem cells

PPAR Research

Volumn , Issue , 2012, Pages

  Takada, Ichiro ^a   Yogiashi, Yoshiko ^a   Kato, Shigeaki ^b  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; FATTY ACID BINDING PROTEIN 4; HISTONE H3; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RUNX2; TROGLITAZONE; WNT5A PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; ENZYME ACTIVITY; EPIGENETIC REPRESSION; HISTONE ACETYLATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84872145720     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/607141     Document Type: Article

References (32)

1. Hamada H., Kobune M., Nakamura K., Kawano Y., Kato K., Honmou O., Houkin K., Matsunaga T., Niitsu Y., Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Science 2005 96 3 149 156 2-s2.0-17744394087 10.1111/j.1349-7006.2005.00032.x (Pubitemid 40575915)
2. Takada I., Kouzmenko A. P., Kato S., Wnt and PPAR γ signaling in osteoblastogenesis and adipogenesis. Nature Reviews. Rheumatology 2009 5 8 442 447 2-s2.0-73349110430
3. Hu E., Tontonoz P., Spiegelman B. M., Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR γ and C/EBP α Proceedings of the National Academy of Sciences of the United States of America 1995 92 21 9856 9860 2-s2.0-0028871780 10.1073/pnas.92.21.9856
4. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 1994 8 10 1224 1234 2-s2.0-0028180070
5. Lecka-Czernik B., Moerman E. J., Grant D. F., Lehmann J. M., Manolagas S. C., Jilka R. L., Divergent effects of selective peroxisome proliferator- activated receptor- γ 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002 143 6 2376 2384 2-s2.0-0036090467 10.1210/en.143.6.2376 (Pubitemid 34521584)
6. Ali A. A., Weinstein R. S., Stewart S. A., Parfitt A. M., Manolagas S. C., Jilka R. L., Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005 146 3 1226 1235 2-s2.0-14244250617 10.1210/en.2004-0735 (Pubitemid 40289310)
7. Rzonca S. O., Suva L. J., Gaddy D., Montague D. C., Lecka-Czernik B., Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004 145 1 401 406 2-s2.0-0347719481 10.1210/en.2003-0746 (Pubitemid 38094536)
8. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U. I., Kubota N., Terauchi Y., Harada Y., Azuma Y., Nakamura K., Kadowaki T., Kawaguchi H., PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. Journal of Clinical Investigation 2004 113 6 846 855 2-s2.0-2142652189 10.1172/JCI200419900 (Pubitemid 38544143)
9. hyp/hyp mice relocates haematopoiesis to the spleen. EMBO Reports 2004 5 10 1007 1012 2-s2.0-8844226036 10.1038/sj.embor.7400254 (Pubitemid 39534460)
10. Hong J. H., Hwang E. S., McManus M. T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B. M., Sharp P. A., Hopkins N., Yaffe M. B., TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005 309 5737 1074 1078 2-s2.0-23644431709 10.1126/science.1110955 (Pubitemid 41134465)
11. Ng F., Boucher S., Koh S., Sastry K. S. R., Chase L., Lakshmipathy U., Choong C., Yang Z., Vemuri M. C., Rao M. S., Tanavde V., PDGF, tgf-2. And FGF signaling is important for differentiation and growth of mesenchymal stem cells (mscs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008 112 2 295 307 2-s2.0-47649121002 10.1182/blood-2007-07-103697
12. Ross S. E., Hemati N., Longo K. A., Bennett C. N., Lucas P. C., Erickson R. L., MacDougald O. A., Inhibition of adipogenesis by Wnt signaling. Science 2000 289 5481 950 953 2-s2.0-0034637103 10.1126/science.289.5481.950 (Pubitemid 30659947)
13. Baron R., Rawadi G., Roman-Roman S., Wnt signaling: a key regulator of bone mass. Current Topics in Developmental Biology 2006 76 103 127 2-s2.0-33751032130 10.1016/S0070-2153(06)76004-5 (Pubitemid 44760540)
14. Glass D. A., Bialek P., Ahn J. D., Starbuck M., Patel M. S., Clevers H., Taketo M. M., Long F., McMahon A. P., Lang R. A., Karsenty G., Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell 2005 8 5 751 764 2-s2.0-20244373613 10.1016/j.devcel.2005.02. 017 (Pubitemid 40585297)
15. Gong Y., Slee R. B., Fukai N., Rawadi G., Roman-Roman S., Reginato A. M., Wang H., Cundy T., Glorieux F. H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W. N., Allgrove J., Arslan-Kirchner M., Batch J. A., Beighton P., Black G. C. M., Boles R. G., Boon L. M., Borrone C., Brunner H. G., Carle G. F., Dallapiccola B., De Paepe A., Floege B., Halfhide M. L., Hall B., Hennekam R. C., Hirose T., Jans A., Jüppner H., Kim C. A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R. S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., Van den Boogaard M. J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B. R., Warman M. L., Warman M. L., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 107 4 513 523 2-s2.0-18044386744 10.1016/S0092-8674(01)00571-2 (Pubitemid 33152786)
16. Krishnan V., Bryant H. U., MacDougald O. A., Regulation of bone mass by Wnt signaling. Journal of Clinical Investigation 2006 116 5 1202 1209 2-s2.0-33646433058 10.1172/JCI28551
17. Manolagas S. C., Almeida M., Gone with the Wnts: β -catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Molecular Endocrinology 2007 21 11 2605 2614 2-s2.0-35648929883 10.1210/me.2007-0259 (Pubitemid 350035144)
18. Veeman M. T., Axelrod J. D., Moon R. T., A second canon: functions and mechanisms of β -catenin-independent Wnt signaling. Developmental Cell 2003 5 3 367 377 2-s2.0-0041695485 10.1016/S1534-5807(03)00266-1 (Pubitemid 37107667)
19. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M. Y., Takeyama K. I., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S., A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR- γ transactivation. Nature Cell Biology 2007 9 11 1273 1285 2-s2.0-35748960839 10.1038/ncb1647 (Pubitemid 350042359)
20. Wakabayashi K. I., Okamura M., Tsutsumi S., Nishikawa N. S., Tanaka T., Sakakibara I., Kitakami J. I., Ihara S., Hashimoto Y., Hamakubo T., Kodama T., Aburatani H., Sakai J., The peroxisome proliferator-activated receptor γ /retinoid X receptor α heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Molecular and Cellular Biology 2009 29 13 3544 3555 2-s2.0-67650070982 10.1128/MCB.01856-08
21. Maeda K., Kobayashi Y., Udagawa N., Uehara S., Ishihara A., Mizoguchi T., Kikuchi Y., Takada I., Kato S., Kani S., Nishita M., Marumo K., Martin T. J., Minami Y., Takahashi N., Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nature Medicine 2012 18 3 405 412 10.1038/nm.2653
22. Miyazono K., Maeda S., Imamura T., BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine and Growth Factor Reviews 2005 16 3 251 263 2-s2.0-21344455768 10.1016/j.cytogfr.2005.01.009 (Pubitemid 40910315)
23. Dohzono S., Imai Y., Nakamura H., Wakitani S., Takaoka K., Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous β -TCP granules: a pilot study. Clinical Orthopaedics and Related Research 2009 467 12 3206 3212 2-s2.0-70449532196 10.1007/s11999-009-0960-1
24. Rosen V., BMP2 signaling in bone development and repair. Cytokine and Growth Factor Reviews 2009 20 5-6 475 480 2-s2.0-70649094222 10.1016/j.cytogfr.2009.10.018
25. Ogawa M., Nishikawa S., Ikuta K., Yamamura F., Naito M., Takahashi K., Nishikawa S., B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac. The EMBO Journal 1988 7 5 1337 1343 2-s2.0-0024003645
26. Nishii N., Arai M., Yanai N., Togari A., Nakabayashi T., Effect of bone morphogenetic protein-2 (BMP-2) or troglitazone, as an inducer of osteogenic cells or adipocytes, on differentiation of a bone marrow mesenchymal progenitor cell line established from temperature-sensitive (ts) simian virus (SV) 40 T-antigen gene transgenic mice. Biological & Pharmaceutical Bulletin 2009 32 1 10 17 10.1248/bpb.32.10
27. Moerman E. J., Teng K., Lipschitz D. A., Lecka-Czernik B., Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR- γ 2 transcription factor and TGF- β /BMP signaling pathways. Aging Cell 2004 3 6 379 389 2-s2.0-13844257282 10.1111/j.1474-9728.2004.00127.x (Pubitemid 40246708)
28. Chawla A., Boisvert W. A., Lee C. H., Laffitte B. A., Barak Y., Joseph S. B., Liao D., Nagy L., Edwards P. A., Curtiss L. K., Evans R. M., Tontonoz P., A PPAR γ -LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 2001 7 1 161 171 2-s2.0-17744376173 10.1016/S1097-2765(01)00164-2 (Pubitemid 32162909)
29. Sugii S., Evans R. M., Epigenetic codes of PPAR γ in metabolic disease. FEBS Letters 2011 585 13 2121 2128 2-s2.0-79959824776 10.1016/j.febslet.2011.05.007
30. Wu S. C., Zhang Y., Minireview: role of protein methylation and demethylation in nuclear hormone signaling. Molecular Endocrinology 2009 23 9 1323 1334 10.1210/me.2009-0131
31. Zeitouni S., Krause U., Clough B. H., Halderman H., Falster A., Blalock D. T., Chaput C. D., Sampson H. W., Gregory C. A., Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Science Translational Medicine 2012 4 132 132ra155 10.1126/scitranslmed.3003396
32. Mullen A. C., Orlando D. A., Newman J. J., Loven J., Kumar R. M., Bilodeau S., Reddy J., Guenther M. G., DeKoter R. P., Young R. A., Master transcription factors determine cell-type-specific responses to TGF- β signaling. Cell 2011 147 3 565 576 10.1016/j.cell.2011.08.050